Serum Heparanase Level Is Decreased in Stable Coronary Artery Disease

OBJECTIVE: Heparanase (HPA), mammalian endo-β-D-glu­cu­ronidase, separates heparan sulfate chains of proteoglycans and changes the structure of the extracellular matrix. We investigated whether serum levels of HPA differ in patients with stable coronary artery disease (SCAD) and subjects with normal...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Med Princ Pract
Autors principals: Gurbuz, Ahmet Seyfeddin, Ozturk, Semi, Efe, Suleyman Cagan, Yilmaz, Mehmet Fatih, Yanik, Raziye Ecem, Yaman, Ali, Kirma, Cevat
Format: Artigo
Idioma:Inglês
Publicat: S. Karger AG 2019
Matèries:
Original Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6944950/
https://ncbi.nlm.nih.gov/pubmed/31480068
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000503085
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars